Glibenclamide therapy: pros and cons

The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibe...

Full description

Bibliographic Details
Main Authors:	Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2011-09-01
Series:	Сахарный диабет
Subjects:	diabetes mellitus type 2 glibenclamide hypoglysemia mortality
Online Access:	https://dia-endojournals.ru/dia/article/viewFile/6231/3990

id	doaj-176cc5d7a32949878807dfda4fd62a37
record_format	Article
spelling	doaj-176cc5d7a32949878807dfda4fd62a372021-06-02T19:24:49ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782011-09-01143929610.14341/2072-0351-62316189Glibenclamide therapy: pros and consOlga Konstantinovna Vikulova0Marina Vladimirovna Shestakova1Endocrinology Research Centre, MoscowEndocrinology Research Centre, MoscowThe safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)https://dia-endojournals.ru/dia/article/viewFile/6231/3990diabetes mellitus type 2glibenclamidehypoglysemiamortality
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova
spellingShingle	Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova Glibenclamide therapy: pros and cons Сахарный диабет diabetes mellitus type 2 glibenclamide hypoglysemia mortality
author_facet	Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova
author_sort	Olga Konstantinovna Vikulova
title	Glibenclamide therapy: pros and cons
title_short	Glibenclamide therapy: pros and cons
title_full	Glibenclamide therapy: pros and cons
title_fullStr	Glibenclamide therapy: pros and cons
title_full_unstemmed	Glibenclamide therapy: pros and cons
title_sort	glibenclamide therapy: pros and cons
publisher	Endocrinology Research Centre
series	Сахарный диабет
issn	2072-0351 2072-0378
publishDate	2011-09-01
description	The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)
topic	diabetes mellitus type 2 glibenclamide hypoglysemia mortality
url	https://dia-endojournals.ru/dia/article/viewFile/6231/3990
work_keys_str_mv	AT olgakonstantinovnavikulova glibenclamidetherapyprosandcons AT marinavladimirovnashestakova glibenclamidetherapyprosandcons
_version_	1721401687112941568

Glibenclamide therapy: pros and cons

Similar Items